News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
12 09 2014 As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), today announced that its Simplexa™ Flu A/B & RSV Direct Kit has received FDA...
-
12 04 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share,...
-
12 01 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Piper Jaffray 26th Annual Healthcare...
-
11 05 2014 - Company Expects to Generate 2% to 5% Revenue Growth and Adjusted Diluted EPS Growth of 8% to 10% on Average Over Next Three Years -At a meeting with analysts and investors at its Investor Day here today, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
-
11 04 2014 First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancerQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced BRCAvantage Plus, the company's first suite of lab-developed test services for...
-
10 23 2014 Revenues from continuing operations of $1.9 billion, up 6.5% versus prior year Adjusted diluted EPS from continuing operations of $1.10, up 7.8% versus prior year Reported diluted EPS from...
-
10 22 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Jeffrey M. Leiden, M.D., Ph.D., to serve as...
-
10 07 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2014 results on Thursday, October 23, 2014, before the...
-
10 02 2014 Congresswoman Niki Tsongas, Representative Danielle Gregoire and Marlborough Mayor Arthur Vigeant join community event to open 200,000 square-foot "lab of the future" designed to deliver innovative, efficient diagnostic information services to New EnglandQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled its new, state-of-the-art clinical test laboratory in Marlborough, Massachusetts with...
-
10 01 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, will host Investor Day for institutional investors and financial analysts...
-
10 01 2014 Former president and CEO of Mayo Medical Laboratories and chair of lab medicine and pathology for Mayo Clinic to oversee Quest's clinical testing operationsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Franklin R. Cockerill, III, M.D., has joined the company as vice president and...
-
09 12 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today celebrates a decade on the North America Dow Jones Sustainability Index (DJSI) and 11...
-
09 11 2014 Colorado and Washington experience surges in marijuana tests positivity rate, but data suggests state legalization of recreational marijuana may not be sole driver of increasesThe percentage of positive drug tests among American workers has increased for the first time in more than a decade, fueled by a rise in marijuana and amphetamines, according to an analysis of 8.5...
-
09 08 2014 Clinical testing volume and positivity rate both grew after the first case of the infectious disease spread to Western Hemisphere this yearA growing number of patients in the United States are being tested – and testing positive – for the mosquito-borne chikungunya virus, according to a study presented at the Interscience...
-
09 04 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
-
08 27 2014 Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomesA novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and...
-
08 15 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share,...
-
07 24 2014 Revenues from continuing operations of $1.9 billion, up 4.8% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 1.9% versus prior year Reported diluted EPS from...
-
07 23 2014 Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective...
-
07 16 2014 Three-year analysis of more than 1.4 million test results also shows majority of Americans continue to put health at risk through dangerous drug combinations and skipping dosesFive states that have implemented multi-faceted prescription drug abuse prevention programs in recent years showed the highest rate of decline in prescription drug misuse rates nationwide,...
-
07 07 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2014 results on Thursday, July 24, 2014, before the...
-
06 10 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new cancer test service based on the FDA-approved THxID®-BRAF test from...
-
06 04 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs 35th Annual Global...
-
06 01 2014 Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance researchMemorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,...
-
05 21 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share,...
-
05 05 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 39th Annual Heath Care...
-
04 28 2014 Company scientists advance understanding of role of genetics in seizure disorders, Charcot-Marie-Tooth disease and other conditions at top neurology industry conferenceQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that several scientists from its Athena Diagnostics specialty neurology business...
-
04 24 2014 Full year revenue and adjusted earnings per diluted share guidance unchanged First quarter adjusted diluted EPS from continuing operations of $0.84, vs. $0.89 in 2013 First quarter adjusted...
-
04 23 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Steward Health Care System LLC (Steward), New England's largest community-based accountable care...
-
04 23 2014 Test test test test twoQuest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, has signed a definitive agreement to manage the clinical testing laboratory at Charlotte Hungerford Hospital, a general acute care hospital in Torrington, Connecticut.
-
04 23 2014 Quest Diagnostics' specialty neurology business unveils 10 new epilepsy diagnostic services, including industry's first clinical multi-analyte test for autoimmune epilepsyQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a suite of new testing services from its Athena Diagnostics specialty neurology...
-
04 21 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has completed the previously announced acquisition of Summit Health, a leading provider of on-site...
-
04 07 2014 Company launches new website to enable patients to access lab data under federal rule that takes effect todayFor the first time, Americans nationwide can directly access their personal laboratory data through Quest Diagnostics (NYSE: DGX), the world's leading...
-
04 03 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2014...
-
03 24 2014 Quest Diagnostics business launches first HSV PCR for CSF in United States. Test provides results in about 60 minutes.Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information and services, today announced that its Focus...
-
03 12 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer...
-
03 11 2014 Combined Offering to Accelerate Growth from Prevention and Wellness ProgramsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive...
-
03 10 2014 - Full Year 2014 Revenues expected to grow 2% - 4% compared to 2013Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously...
-
02 26 2014 Company Supports March's Colorectal Cancer Awareness Month by Participating in the One Million Strong Screening Event in New York City on March 3Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced new pathology and blood test...
-
02 24 2014 Retired New York Giants Player Stephen Baker to Join Quest as it Provides 100 Complimentary Blueprint for Wellness® Profiles at Booth 3064 on February 25Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will exhibit at booth 3064 and host a series of "Tech...
-
02 17 2014 -- John B. Haydon transitions to Vice President, Joint Ventures and Strategic ProgramsQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced a series of senior leadership...
-
02 14 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
-
02 12 2014 Enabling Health Systems to Qualify for CMS Financial IncentivesChartMaxx, the enterprise content management (ECM) solution from Quest Diagnostics (NYSE:DGX), has achieved 2014 Edition Modular EHR*...
-
02 05 2014 ChartMaxx Enterprise Content Management System Honored with Top Ranking for the Ninth TimeQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise...
-
02 04 2014 The Quest Diagnostics Health Trends™ study of 2.7 million test results is the largest to examine warfarin treatment in patients with atrial fibrillation (Afib) treated in primary care and other non-hospital care settings in the United StatesApproximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk of stroke or bleeding when treated with the most...
-
02 03 2014 A final rule issued today by the U.S. Department of Health and Human Services (HHS) giving Americans increased access to their personal health...
-
01 30 2014 Fourth quarter adjusted diluted EPS from continuing operations of $1.03, 2% above prior year Fourth quarter reported diluted EPS from continuing...
-
01 22 2014 Transaction to give patients and healthcare providers in the Southeastern United States greater access to innovative and cost-effective diagnostic information servicesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive...
-
01 17 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full...
-
01 13 2014 Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected...